Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-179652
Filing Date
2026-04-27
Accepted
2026-04-27 09:41:06
Documents
26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d143046ddefa14a.htm DEFA14A 729134
2 GRAPHIC g139894g0427135026198.jpg GRAPHIC 3278
3 GRAPHIC g143046ex99_2s10g1.jpg GRAPHIC 27947
4 GRAPHIC g143046ex99_2s11g1.jpg GRAPHIC 104228
5 GRAPHIC g143046ex99_2s12g1.jpg GRAPHIC 122606
6 GRAPHIC g143046ex99_2s13g1.jpg GRAPHIC 107657
7 GRAPHIC g143046ex99_2s14g1.jpg GRAPHIC 27214
8 GRAPHIC g143046ex99_2s15g1.jpg GRAPHIC 117013
9 GRAPHIC g143046ex99_2s16g1.jpg GRAPHIC 118840
10 GRAPHIC g143046ex99_2s17g1.jpg GRAPHIC 110822
11 GRAPHIC g143046ex99_2s18g1.jpg GRAPHIC 109535
12 GRAPHIC g143046ex99_2s19g1.jpg GRAPHIC 117162
13 GRAPHIC g143046ex99_2s1g1.jpg GRAPHIC 58685
14 GRAPHIC g143046ex99_2s20g1.jpg GRAPHIC 90914
15 GRAPHIC g143046ex99_2s21g1.jpg GRAPHIC 163324
16 GRAPHIC g143046ex99_2s22g1.jpg GRAPHIC 26237
17 GRAPHIC g143046ex99_2s23g1.jpg GRAPHIC 41351
18 GRAPHIC g143046ex99_2s24g1.jpg GRAPHIC 69837
19 GRAPHIC g143046ex99_2s2g1.jpg GRAPHIC 252282
20 GRAPHIC g143046ex99_2s3g1.jpg GRAPHIC 140038
21 GRAPHIC g143046ex99_2s4g1.jpg GRAPHIC 39084
22 GRAPHIC g143046ex99_2s5g1.jpg GRAPHIC 138488
23 GRAPHIC g143046ex99_2s6g1.jpg GRAPHIC 99579
24 GRAPHIC g143046ex99_2s7g1.jpg GRAPHIC 79278
25 GRAPHIC g143046ex99_2s8g1.jpg GRAPHIC 126634
26 GRAPHIC g143046ex99_2s9g1.jpg GRAPHIC 137787
  Complete submission text file 0001193125-26-179652.txt   4079865
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 26897108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)